MassMutual Private Wealth & Trust’s Amneal Pharmaceuticals AMRX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.3K	Hold	652	–	–	﹤0.01%	1352
2026 Q1	$8.1K	Hold	652	–	–	﹤0.01%	1452
2025 Q4	$8.21K	Hold	652	–	–	﹤0.01%	1473
2025 Q3	$6.53K	Buy	652 +284	+77%	+$2.55K	﹤0.01%	1573
2025 Q2	$2.98K	Sell	368 -136	-27%	-$1.02K	﹤0.01%	1827
2025 Q1	$4.22K	Buy	504 +380	+306%	+$3.17K	﹤0.01%	1663
2024 Q4	$982	Buy	+124	New	+$1.04K	﹤0.01%	2024
2018 Q3	–	Sell	-52	Closed	-$853	–	972
2018 Q2	$853	Buy	+52	New	+$913	﹤0.01%	1026

Other funds holding AMRX

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

Stonebridge Financial Group (Pennsylvania) Wormleysburg, Pennsylvania $1.32B AUM 23.07% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return